Molecular Tumour Board

The VCCC Molecular Tumour Board (MTB) is a multi-disciplinary style forum that provides opinion on the clinical implications of molecular pathology test results of tumours.

Each case is discussed on an individual, de-identified basis. Most MTB meetings also feature an educational presentation.

Discussion and assessment of molecular pathology results

The MTB is convened by Dr Stephen Luen with an expert group comprised of clinical and scientific staff from across the VCCC providing opinion on each case.  

The MTB educational and research presentations provide an excellent opportunity to learn more about personalised medicine. CPD points are available for meeting attendance. The MTB welcomes referrals from any clinician or multi-disciplinary team from VCCC members and collaborators.

Clinicians, scientists and students (from any organisation) are welcome to attend the meetings, which are held on Fridays.  

 

Meeting details

2:45 - 4:00pm 

If you would like to receive meeting agendas, be added to the mailing list or have other enquiries, please contact Justine Ellis, VCCC Associate Head of Research Development.

In accordance with our COVID-19 precautions the MTB will be run online until further notice.

 

 

 

Friday 16 October 

Education presentation

Restoring interactions between tumour and immune cells to combat metastasis

  • Associate Professor Belinda Parker, Microenvironmental Crosstalk and Therapeutics laboratory in the Cancer Immunology and Therapeutics programs at Peter MacCallum Cancer Centre

Clinical presentations (to be confirmed)

 

 

Friday 20 November

Education presentation

 A year in review - the VCCC Precision Oncology Program

  • Dr Stephen Luen (Medical Oncology Consultant - Breast, Sarcoma, Early Drug Development and PhD student, Translational Breast Cancer Genomics and Therapeutics Lab - Loi Lab, Peter MacCallum Cancer Centre)

 

 

Future dates and speakers to be confirmed for 2021

  

 

Case submission

We welcome cases from clinicians whose patients have had molecular pathology testing performed as part of clinical care or research. Experts will provide advice and opinion regarding the clinical implications of the molecular pathology findings. Wherever possible, referring clinicians will also be advised on appropriate available clinical trials.

To submit a case to the MTB, please complete the MTB case form template and send via email to Justine Ellis, VCCC Associate Head Research Development.